News | Therapoid

Open Therapeutics and American Impact Capital Foundation Form Alliance.

Published on: — Dec. 12, 2022, 4:17 a.m.

Download as PDF Copy Link

American Impact Capital Foundation Provides Non-Fungible Token (NFT) and Cryptocurrency Holders a Route for Philanthropic and Charitable Giving

Cincinnati, OH and Westport, CT — December 12th, 2022 — Open Therapeutics, an open science company, announces an alliance with American Impact Capital Foundation . Through this alliance, members of the Open Therapeutic' Therapoid community who wish to donate their NFTs and cryptocurrency assets to charities now have a unique pathway to do so.

Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentralized Autonomous Organization (PolygonDAO).

Published on: — Nov. 8, 2022, 9:02 a.m.

Download as PDF Copy Link

Through this award, Open Therapeutics will accelerate its Web3.0 Polygon blockchain implementation.

Cincinnati, OH, and Polygon DAO — November 8, 2022 — Open Therapeutics an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO).

Open Therapeutics and IPwe Form an Intellectual Property Partnership.

Published on: — Sept. 14, 2022, 4:17 a.m.

Download as PDF Copy Link

Through a partnership to enhance the licensing of intellectual properties, the companies will work to jointly encourage the licensing of IP portfolios

Cincinnati, OH, and Paris, France — September 14th, 2022 — Open Therapeutics, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics, and blockchain technology around smart intangible asset management, announce their collaboration to jointly advance the licensing of intellectual property.

Open Therapeutics to Exhibit at the American Society of Gene & Cell Therapy (ASGCT) Annual Conference, 15-19 May, 2022, Washington, DC.

Published on: — May 18, 2022, 4:17 a.m.

Download as PDF Copy Link

Providing Information about the Open Therapeutics’ Therapoid Open Science Platform.

Cincinnati, OH — May 16th, 2022 — Open Therapeutics, an open science company, announces its Chair and interim CEO, Jason E. Barkeloo, will lead a the Open Therapeutics booth exhibit at the American Society of Gene & Cell Therapy (ASGCT) conference at the Walter E. Washington Convention Center, 801 Mt. Vernon Pl NW, Washington DC.

Amsterdam ETHAmsterdam news release

Published on: — April 11, 2022, 4:17 a.m.

Download as PDF Copy Link

Open Therapeutics Chair and CEO to Lead Decentralized Science (DeSci) and Open Science Panel at Devconnect Week, Amsterdam, Neatherlands, Wednesday, April 20, 2022.

The Potential Impact of Decentralized Autonomous Organizations (DAO) to Open Science and Open Access. Cincinnati, OH — April 11^th, 2022 — Open Therapeutics, an open science company, announces its Chair and interim CEO, Jason E. Barkeloo, will lead an open science, open access, and DAO panel discussion at Devconnect Week, April 18^th – April 25^th, Beurs Van Berlage, Netherlands, entitled, “The Potential Impact of Decentralized Autonomous Organizations (DAO) to Open Science and Open Access”.